Isabelle Lefebvre

Ms. Lefebvre brings over 30 years of regulatory affairs experience in pharmaceuticals, biologics, and medical devices across all phases of development. She joins EyePoint from Hengrui USA, where she served as Vice President, Head of Regulatory Science, overseeing its U.S. and E.U. regulatory strategies for their development programs.

Ms. Lefebvre has strong Ophthalmic/Ocular experience having spent nearly a decade of her career at Bausch & Lomb where she led the successful approvals of both LOTEMAX gel and VYZULTA®. She has also held prominent positions in regulatory at Valeant Pharmaceuticals, Lundbeck, and Alpharma Pharmaceuticals.

Ms. Lefebvre holds a Master’s in Regulatory Affairs from Northeastern University and a Bachelor of Science in Biochemistry from The University of Montreal.